Acute hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35036
Nova Scotia Health Authority. QEII. Nephrology Services.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1151
- Available Online
- View Pamphlet
Hemodialysis is a treatment that uses a machine to filter your blood and remove waste and extra water from your blood. Topics include: what your kidneys do, what acute kidney failure is, what peritoneal dialysis is, what hemodialysis is, and how to live with kidney disease. A resource list is also given.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Nephrology Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (8 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Acute Kidney Injury
- Kidney Diseases - therapy
- Subjects (LCSH)
- Hemodialysis
- Acute renal failure
- Abstract
- Hemodialysis is a treatment that uses a machine to filter your blood and remove waste and extra water from your blood. Topics include: what your kidneys do, what acute kidney failure is, what peritoneal dialysis is, what hemodialysis is, and how to live with kidney disease. A resource list is also given.
- Responsibility
- Prepared by: Nephrology Services
- Pamphlet Number
- 1151
Are you on dialysis, taking blood thinners, and need an interventional radiology procedure?
https://libcat.nshealth.ca/en/permalink/chpams35344
Nova Scotia Health Authority. QEII. Pharmacy Services, Nova Scotia Health Authority. QEII. Vascular Access Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1444
- Available Online
- View Pamphlet
This pamphlet gives directions for dialysis patients on warfarin who are having an interventional radiology procedure. The pamphlet explains what an interventional radiology procedure is. Space is provided to write the name and date of your procedure, as well as instructions to follow before and after your procedure. Instructions about what to do if you notice any bleeding or bruising in the area of your body where the procedure was done are included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Services
- Nova Scotia Health Authority. QEII. Vascular Access Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Nephrology
- Warfarin
- Renal Dialysis
- Radiology, Interventional
- Subjects (LCSH)
- Nephrology
- Hemodialysis
- Warfarin
- Interventional radiology
- Specialty
- Nephrology
- Abstract
- This pamphlet gives directions for dialysis patients on warfarin who are having an interventional radiology procedure. The pamphlet explains what an interventional radiology procedure is. Space is provided to write the name and date of your procedure, as well as instructions to follow before and after your procedure. Instructions about what to do if you notice any bleeding or bruising in the area of your body where the procedure was done are included.
- Notes
- Previous title: Hemodialysis instead of dialysis
- Previous title: Dialysis patients on Warfarin who need interventional radiology procedures
- Responsibility
- Prepared by: Pharmacy Services, Vascular Access Services
- Pamphlet Number
- 1444
Care of your arteriovenous fistula
https://libcat.nshealth.ca/en/permalink/chpams35622
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 0651
- Available Online
- View Pamphlet
An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Central Venous Catheters
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Specialty
- Nephrology
- Abstract
- An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 0651
Dalteparin (Fragmin) to prevent clotting during hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2020.
- Pamphlet Number
- 1760
- Available Online
- View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Dalteparin
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Blood--coagulation
- Specialty
- Nephrology
- Abstract
- Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1760
Fer injectable et insuffisance rénale chronique (IRC)
https://libcat.nshealth.ca/en/permalink/chpams37473
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2020.
- Pamphlet Number
- 2161
- Available Online
- View Pamphlet
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygè…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Alternate Title
- Injectable iron and chronic kidney disease (CKD)
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Iron - therapeutic use
- Kidney Diseases
- Anemia, Iron-Deficiency
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure--Complications
- Iron deficiency anemia
- Abstract
- Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygène. Ce dépliant explique comment prendre du fer injectable, ses effets possibles et comment le conserver.
- This pamphlet is a French translation of the English pamphlet 1495, "Injectable Iron and Chronic Kidney Disease (CKD)". If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how to take injectable iron, side effects to watch for, and instructions on how to store the medication.
- Notes
- Previous title: Injectable iron sucrose and chronic kidney disease
- Responsibility
- Prepared by: NSHA Renal Program
- Pamphlet Number
- 2161
Home therapy options for dialysis
https://libcat.nshealth.ca/en/permalink/chpams35224
Nova Scotia Health Authority. Home Dialysis Unit.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1341
- Available Online
- View Pamphlet
Staff in the Home Dialysis Unit at the Queen Elizabeth II Health Sciences Centre (QEII) teach patients how to do dialysis treatments at home. This pamphlet gives information about where to stay if you live more than 40 km (25 miles) from Halifax, the dialysis training process, supplies, and follow-up. Different types of dialysis are explained.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Home Dialysis Unit
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (10 p.) : digital, PDF file
- Subjects (MeSH)
- Hemodialysis, Home
- Subjects (LCSH)
- Home hemodialysis
- Specialty
- Nephrology
- Abstract
- Staff in the Home Dialysis Unit at the Queen Elizabeth II Health Sciences Centre (QEII) teach patients how to do dialysis treatments at home. This pamphlet gives information about where to stay if you live more than 40 km (25 miles) from Halifax, the dialysis training process, supplies, and follow-up. Different types of dialysis are explained.
- Responsibility
- Prepared by: Home Dialysis Unit
- Pamphlet Number
- 1341
In-centre hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35162
Nova Scotia Health Authority. Central Zone. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1220
- Available Online
- View Pamphlet
This pamphlet is for patients who are beginning dialysis. It explains what to expect when starting hemodialysis, common questions you may have, your hemodialysis schedule, and your hemodialysis health care team. Information about Patient Rights and Responsibilities, Patient Relations, and Ethics is included. The pamphlet also includes a list of resources and words you may hear during your treatment. A blank Hemodialysis Care Plan, Hemodialysis Tracking Sheet, and Hemodialysis checklist are also…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Central Zone. Renal Program
- Alternate Title
- In centre hemodialysis
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (24 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Kidney Diseases - therapy
- Subjects (LCSH)
- Hemodialysis
- Kidneys--Diseases
- Specialty
- Nephrology
- Abstract
- This pamphlet is for patients who are beginning dialysis. It explains what to expect when starting hemodialysis, common questions you may have, your hemodialysis schedule, and your hemodialysis health care team. Information about Patient Rights and Responsibilities, Patient Relations, and Ethics is included. The pamphlet also includes a list of resources and words you may hear during your treatment. A blank Hemodialysis Care Plan, Hemodialysis Tracking Sheet, and Hemodialysis checklist are also included.
- Notes
- Previous titles: Renal (dialysis) patient handbook, Hemodialysis patient handbook
- Responsibility
- Prepared by: Renal Program, Central Zone
- Pamphlet Number
- 1220
Injectable iron and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1495
- Available Online
- View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Iron - therapeutic use
- Kidney Diseases
- Anemia, Iron-Deficiency
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure--Complications
- Iron deficiency anemia
- Abstract
- Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
- Notes
- Previous title: Injectable iron sucrose and chronic kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1495
Lanthanum (Fosrenol) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1466
- Available Online
- View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Lanthanum
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
- Notes
- Previous title: Fosrenol (Lanthanum) and hemodialysis
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1466
Nocturnal dialysis nutrition guidelines
https://libcat.nshealth.ca/en/permalink/chpams35668
Nova Scotia Health Authority. Nutrition and Food Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1655
- Available Online
- View Pamphlet
Nocturnal Home Hemodialysis (NHHD) is a type of dialysis done at home overnight, usually for 8 to 9 hours, 5 to 6 nights a week. The main parts of the NHHD nutrition plan are protein, phosphorus, sodium (salt), fluids, and potassium. This pamphlet gives information about each of these items, as well as a sample meal plan.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nutrition and Food Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (7 p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases - diet therapy
- Hemodialysis, Home
- Subjects (LCSH)
- Kidneys--Diseases--Nutritional aspects
- Home hemodialysis
- Specialty
- Food and Nutrition
- Abstract
- Nocturnal Home Hemodialysis (NHHD) is a type of dialysis done at home overnight, usually for 8 to 9 hours, 5 to 6 nights a week. The main parts of the NHHD nutrition plan are protein, phosphorus, sodium (salt), fluids, and potassium. This pamphlet gives information about each of these items, as well as a sample meal plan.
- Notes
- Previous title: Nocturnal dialysis diet
- Responsibility
- Prepared by: Nutrition and Food Services
- Pamphlet Number
- 1655
Non-tunneled hemodialysis catheter
https://libcat.nshealth.ca/en/permalink/chpams35618
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1093
- Available Online
- View Pamphlet
A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Vascular Access Devices
- Subjects (LCSH)
- Catheters
- Hemodialysis
- Specialty
- Nephrology
- Abstract
- A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1093
Nutrition guidelines for hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35132
Nova Scotia Health Authority. Nutrition and Food Services.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 0628
- Available Online
- View Pamphlet
This pamphlet is for people with Chronic Kidney Disease (CKD). It gives information about protein, sodium (salt), potassium, and phosphorus, as well as reading food labels, adding calories and flavour, and controlling your fluid intake. A sample meal plan and guidelines for measuring portions are included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nutrition and Food Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (26 p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases - diet therapy
- Phosphorus, Dietary
- Diet, Sodium-Restricted
- Renal Dialysis
- Subjects (LCSH)
- Kidneys--Diseases--Nutritional aspects
- Diet therapy
- Food--Phosphorus content
- Salt-free diet
- Hemodialysis
- Specialty
- Nutrition and food
- Abstract
- This pamphlet is for people with Chronic Kidney Disease (CKD). It gives information about protein, sodium (salt), potassium, and phosphorus, as well as reading food labels, adding calories and flavour, and controlling your fluid intake. A sample meal plan and guidelines for measuring portions are included.
- Notes
- Previous title: Nutrition guidelines for kidney disease
- Previous title: Diet for kidney disease
- Responsibility
- Prepared by: Nutrition and Food Services
- Pamphlet Number
- 0628
One-Alpha® (alfacalcidol) and hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams36672
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1470
- Available Online
- View Pamphlet
One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can ca…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels of in the blood and weaker bones. One-Alpha® raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. One-Alpha® is a brand name for alfacalcidol.
- Responsibility
- Prepared by: Renal Pharmacy Team, Renal Program
- Pamphlet Number
- 1470
Rocaltrol® (calcitriol) and hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1468
- Available Online
- View Pamphlet
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amoun…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Calcitriol
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. Rocaltrol® is a brand name for calcitriol.
- Responsibility
- Prepared by: Renal Pharmacy Team, Renal Program
- Pamphlet Number
- 1468
Sevelamer (Renagel) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1464
- Available Online
- View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Sevelamer
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Abstract
- Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
- Notes
- Previous title: Renagel (Sevelamer) and Hemodialysis
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1464
Tunneled hemodialysis catheter
https://libcat.nshealth.ca/en/permalink/chpams35616
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1032
- Available Online
- View Pamphlet
A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Vascular Access Devices
- Subjects (LCSH)
- Hemodialysis
- Catheters
- Specialty
- Nephrology
- Abstract
- A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1032
